Orchard Exits Life-Saving Bubble-Baby Research in Wake of Flap Over Patient Access
Program Turned over to California Stem Cell Agency and UCLA; Questions Abound
Orchard Therapeutics this morning formally announced it was giving up on its life-saving treatment for the bubble baby disease and turned it over to California’s stem cell agency and UCLA.
In a statement, the company said it could not overcome “technical issues” dealing with manufacturing the treatment, which has saved the lives of 50 children with a ra…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.